Screening in Liver Disease: Report of an AASLD Clinical Workshop

Paul C. Adams, Michael J. Arthur, Thomas D. Boyer, Laurie D. DeLeve, Adrian M. Di Bisceglie, Mark Hall, Theodore R. Levin, Dawn Provenzale, Leonard Seef

Research output: Contribution to journalArticle

44 Scopus citations

Abstract

This report summarizes an AASLD Clinical Workshop that was presented at Digestive Diseases Week 2003 on screening in liver diseases. As newer diagnostic tests become available, many liver diseases and complications of liver disease can be detected at an early asymptomatic stage. In many cases, early detection can lead to earlier treatment and an improved outcome. However, screening for liver diseases in asymptomatic persons has the potential for adverse consequences, including discrimination and stigmatization. The cost of screening programs is significant, and access to screening tests varies in different countries. Future screening programs require careful planning and implementation to balance the benefits, risks, and cost-effectiveness. This review outlines the concepts of screening and their application to a broad range of liver deseases.

Original languageEnglish (US)
Pages (from-to)1204-1212
Number of pages9
JournalHepatology
Volume39
Issue number5
DOIs
StatePublished - May 1 2004

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Screening in Liver Disease: Report of an AASLD Clinical Workshop'. Together they form a unique fingerprint.

  • Cite this

    Adams, P. C., Arthur, M. J., Boyer, T. D., DeLeve, L. D., Di Bisceglie, A. M., Hall, M., Levin, T. R., Provenzale, D., & Seef, L. (2004). Screening in Liver Disease: Report of an AASLD Clinical Workshop. Hepatology, 39(5), 1204-1212. https://doi.org/10.1002/hep.20169